Cardiovascular events after acute coronary syndrome. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Coronary Vessels Blood Platelets Endothelium, Vascular Myocardium Radial Artery Arteries

Organisms3

Chlamydophila pneumoniae Dogs Catha

Diseases62

Acute Coronary Syndrome Syndrome Angina, Unstable Myocardial Infarction Coronary Artery Disease Coronary Disease Acute Disease Coronary Thrombosis Chest Pain Hemorrhage Coronary Stenosis Cardiovascular Diseases Angina Pectoris Myocardial Ischemia Plaque, Atherosclerotic Coronary Vasospasm Recurrence Angina, Stable Stroke Thrombosis Rupture, Spontaneous Coronary Restenosis Coronary Aneurysm Metabolic Syndrome X Vascular Calcification Coronary Occlusion Calcinosis Diabetic Angiopathies Death, Sudden, Cardiac Atherosclerosis Heart Failure Hypertension Diabetes Complications No-Reflow Phenomenon Diabetes Mellitus, Type 2 Inflammation Down Syndrome Diabetes Mellitus Takotsubo Cardiomyopathy Death Heart Diseases Disease Progression Kidney Failure, Chronic Hypercholesterolemia Peripheral Vascular Diseases Postoperative Hemorrhage Necrosis Kidney Diseases Arteriosclerosis Ventricular Dysfunction, Left Arrhythmias, Cardiac Renal Insufficiency, Chronic Chronic Disease Shock, Cardiogenic Hyperlipidemias Chlamydophila Infections Renal Insufficiency Postoperative Complications Hyperglycemia Nephrotic Syndrome Heart Arrest Dyslipidemias

Chemicals and Drugs60

Platelet Aggregation Inhibitors Biological Markers Ticlopidine Platelet Glycoprotein GPIIb-IIIa Complex Troponin T Troponin I Aspirin C-Reactive Protein Purinergic P2Y Receptor Antagonists Hydroxymethylglutaryl-CoA Reductase Inhibitors Heptanoic Acids Creatine Kinase, MB Form Enoxaparin Anticoagulants Cardiovascular Agents Fibrinolytic Agents Pyrroles Troponin Thiophenes Pravastatin Hirudins Acetanilides Heparin Natriuretic Peptide, Brain Anticholesteremic Agents Cholesterol, LDL Creatine Kinase Adrenergic beta-Antagonists Fluorobenzenes Immunoglobulin Fab Fragments Phospholipases A2, Secretory Adenosine Receptors, Purinergic P2Y12 Piperazines Heparin, Low-Molecular-Weight Hypolipidemic Agents Dalteparin Angiotensin-Converting Enzyme Inhibitors Pregnancy-Associated Plasma Protein-A Antithrombins Peptide Fragments Cholesterol, HDL Growth Differentiation Factor 15 Lipids Glycogen Phosphorylase, Brain Form Vasodilator Agents P-Selectin Purinergic P2 Receptor Antagonists Creatinine CD40 Ligand Simvastatin 1-Alkyl-2-acetylglycerophosphocholine Esterase Blood Glucose Neopterin Cholesterol Thromboplastin Sirolimus Antihypertensive Agents Fibrinogen Nadroparin

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Coronary Angiography Angioplasty, Balloon, Coronary Risk Factors Treatment Outcome Prospective Studies Electrocardiography Risk Assessment Predictive Value of Tests Coronary Artery Bypass Follow-Up Studies Percutaneous Coronary Intervention Myocardial Revascularization Prognosis Ultrasonography, Interventional Proportional Hazards Models Hospitalization Stents Kaplan-Meier Estimate Randomized Controlled Trials as Topic Retrospective Studies Incidence Cohort Studies Registries Multivariate Analysis Double-Blind Method Severity of Illness Index Drug Therapy, Combination Chi-Square Distribution Hospital Mortality Logistic Models ROC Curve Angioscopy Case-Control Studies Cardiac Catheterization Sensitivity and Specificity Risk Hirudin Therapy Survival Analysis Thrombolytic Therapy Odds Ratio Platelet Function Tests Epidemiologic Methods Regression Analysis Tomography, X-Ray Computed Endpoint Determination Blood Pressure Survival Rate Echocardiography Drug-Eluting Stents Prevalence Myocardial Reperfusion Cardiac Imaging Techniques Multidetector Computed Tomography Propensity Score Multicenter Studies as Topic Analysis of Variance Coronary Artery Bypass, Off-Pump Patient Selection Stroke Volume Cause of Death Myocardial Perfusion Imaging Patient Readmission Patient Discharge Emergency Treatment Reproducibility of Results Clinical Trials as Topic Statistics, Nonparametric Reference Values Exercise Test Patient Admission Atherectomy, Coronary Glomerular Filtration Rate Length of Stay Blood Flow Velocity Partial Thromboplastin Time Single-Blind Method Diagnostic Techniques, Cardiovascular Thrombectomy Echocardiography, Stress Feasibility Studies Administration, Oral Confidence Intervals Cross-Sectional Studies Pilot Projects

Psychiatry and Psychology1

Phenomena and Processes21

Coronary Circulation Time Factors Chi-Square Distribution Sensitivity and Specificity Platelet Activation Risk Odds Ratio Blood Pressure Platelet Aggregation Stroke Volume Necrosis Dose-Response Relationship, Drug Hemodynamics Ventricular Function, Left Glomerular Filtration Rate Blood Flow Velocity Genotype Vasodilation Partial Thromboplastin Time Polymorphism, Genetic Collateral Circulation

Disciplines and Occupations2

Evidence-Based Medicine Cardiology

Information Science6

Incidence Registries Hospital Mortality Survival Rate Prevalence Cause of Death

Health Care61

Risk Factors Treatment Outcome Prospective Studies Risk Assessment Predictive Value of Tests Follow-Up Studies Coronary Care Units Proportional Hazards Models Hospitalization Kaplan-Meier Estimate Randomized Controlled Trials as Topic Retrospective Studies Incidence Cohort Studies Registries Multivariate Analysis Double-Blind Method Severity of Illness Index Chi-Square Distribution Hospital Mortality Secondary Prevention Logistic Models ROC Curve Case-Control Studies Triage Sensitivity and Specificity Risk Survival Analysis Odds Ratio Age Factors Comorbidity Epidemiologic Methods Regression Analysis Sex Factors Emergency Medical Services Practice Guidelines as Topic Survival Rate Emergency Service, Hospital Prevalence Cardiology Service, Hospital Propensity Score Point-of-Care Systems Multicenter Studies as Topic Analysis of Variance Patient Selection Cause of Death Patient Readmission Patient Discharge Reproducibility of Results Clinical Trials as Topic Statistics, Nonparametric Patient Admission Guideline Adherence Length of Stay American Heart Association Single-Blind Method Cost-Benefit Analysis Feasibility Studies Confidence Intervals Cross-Sectional Studies Pilot Projects

Geographicals8

Albania Japan United States Greece Middle East Europe Switzerland Qatar

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Acute Coronary Syndrome Syndrome Angina, Unstable Myocardial Infarction Coronary Angiography Coronary Artery Disease Coronary Vessels Platelet Aggregation Inhibitors Angioplasty, Balloon, Coronary Coronary Disease Acute Disease Risk Factors Biological Markers Ticlopidine Treatment Outcome Prospective Studies Coronary Thrombosis Chest Pain Coronary Circulation Electrocardiography Risk Assessment Hemorrhage Coronary Stenosis Predictive Value of Tests Cardiovascular Diseases Angina Pectoris Platelet Glycoprotein GPIIb-IIIa Complex Coronary Artery Bypass Troponin T Follow-Up Studies Percutaneous Coronary Intervention Myocardial Revascularization Prognosis Time Factors Troponin I Aspirin Myocardial Ischemia Plaque, Atherosclerotic C-Reactive Protein Purinergic P2Y Receptor Antagonists Hydroxymethylglutaryl-CoA Reductase Inhibitors Heptanoic Acids Creatine Kinase, MB Form Enoxaparin Anticoagulants Ultrasonography, Interventional Coronary Care Units Proportional Hazards Models Hospitalization Coronary Vasospasm Stents Kaplan-Meier Estimate Recurrence Angina, Stable Cardiovascular Agents Fibrinolytic Agents Randomized Controlled Trials as Topic Retrospective Studies Pyrroles Troponin Thiophenes Stroke Incidence Cohort Studies Registries Thrombosis Multivariate Analysis Double-Blind Method Severity of Illness Index Pravastatin Rupture, Spontaneous Coronary Restenosis Drug Therapy, Combination Hirudins Chi-Square Distribution Hospital Mortality Acetanilides Heparin Coronary Aneurysm Secondary Prevention Natriuretic Peptide, Brain Metabolic Syndrome X Logistic Models Vascular Calcification ROC Curve Angioscopy Coronary Occlusion Case-Control Studies Triage Cardiac Catheterization Sensitivity and Specificity Calcinosis Platelet Activation Anticholesteremic Agents Risk Cholesterol, LDL Hirudin Therapy Survival Analysis Diabetic Angiopathies Death, Sudden, Cardiac

No FAQ available that match "cardiovascular events after acute coronary syndrome"